Canopy Growth Corporation (CGC)
Nasdaq · Common stock · Medicinal Chemicals & Botanical Products
As of Oct 21, 3:15 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.
CGC trades thinly or has a short history, so some panels below have little to show.
Follow CGC in real time
Real-time quotes, Pro Charting, the scanner and the alert feed on CGC and every other US listing.
Start 5 days freeTry Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
CGC at a glance
Key statistics
$304.59M
Market capitalization
- Previous close
- $0.7200
- Open
- $0.7210
- Day range
- $0.6630 – $0.7310
- Volume
- 3.52M
- Average volume (30 sessions)
- 2.43M
- Shares outstanding
- 423.35M
- Earnings per share
- $(0.40)
- Price / book
- 0.6
- Price / sales
- 1.3
- Beta (1 year, vs SPY)
- 1.26
Where the price sits in its year
52-week range
0% of the range
- Below the 52-week high
- -72.1%
- Above the 52-week low
- 0.0%
Completed sessions through Oct 20, 2026
Technical snapshot
Below its 50-day and 200-day averages
- 20-day average
- $0.8377-14.1%
- 50-day average
- $0.9262-22.3%
- 200-day average
- $1.02-29.6%
In the band below 30 that convention calls oversold. Weak trends can stay there for weeks.
-5.6%
1 week
-22.1%
1 month
-20.9%
3 months
-36.8%
Year to date
-45.0%
1 year
Price change over each window, from completed sessions. Past performance does not indicate future results.
Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.The member platform, in real time
What members do with CGC
CGC on Pro Charting
Every intraday interval in real time, the drawing kit and the full set of technical studies on CGC.
See the plans →
Every planScreen names like CGC
The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.
See the plans →
Analysis Tools OnlySet a price line on CGC
Put CGC on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.
See the plans →
Stock Alerts + ToolsOpen alerts on CGC
See whether there is an open premium alert on CGC, with its entry, stop and exit, each one reviewed by an analyst before it is sent.
See the plans →
From the public news wire
CGC headlines
- MTL Cannabis Announces Shareholder Approval of Arrangement with Canopy Growth
Benzinga · Feb 18, 2026
- MTL Cannabis Reminds MTL Shareholders to Vote FOR the Arrangement Resolution to Approve the Proposed Plan of Arrangement with Canopy Growth at the Upcoming Special Meeting of MTL Shareholders
Benzinga · Feb 10, 2026
- Independent Proxy Advisory Firms, ISS and Glass Lewis, Recommend MTL Shareholders Vote FOR the Arrangement Resolution with Canopy Growth
Benzinga · Feb 5, 2026
- MTL Cannabis Announces Mailing of the Management Information Circular in Connection with its Special Meeting of Shareholders to Approve the Acquisition by Canopy Growth
Benzinga · Jan 27, 2026
- Canopy Growth To Acquire MTL Cannabis
Benzinga · Dec 15, 2025
SEC Form 4, most recent first
Insider filings
BAYERN JOSEPH
−3.1K
Director · Open-market sale
$2.87K · Sep 28, 2026
Yanofsky Theresa
−14.9K
Director · Open-market sale
$13.83K · Sep 28, 2026
ATKINS M SHAN
−3.1K
Director · Open-market sale
$2.87K · Sep 28, 2026
Lazzarato David Angelo
−22.4K
Director · Open-market sale
$20.74K · Sep 28, 2026
Stewart Thomas Carlton
−25.8K
See Remarks · Open-market sale
$23.95K · Sep 17, 2026
Gedeon Christelle
−13.3K
See Remarks · Open-market sale
$19.62K · Aug 24, 2026
Stewart Thomas Carlton
−2.2K
See Remarks · Open-market sale
$3.28K · Aug 24, 2026
ATKINS M SHAN
−3.2K
Director · Open-market sale
$2.95K · Jun 26, 2026
About Canopy Growth Corporation
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.
- Exchange
- Nasdaq
- Security
- Common stock
- Industry
- Medicinal Chemicals & Botanical Products
- Headquarters
- Smith Falls, A6
- Employees
- 1,128
- Listed since
- Apr 7, 2014
- Website
- canopygrowth.com
Pick the desk that fits how you trade
Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.
Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.